AstraZeneca

Kentz, Victoria, AstraZeneca, and SSE

A number of companies on which ShareSoc has commented recently were in the news today (23/6/2014) or over the preceding weekend. Let's cover each in turn: Kentz Kentz received a cash offer for the company of 935p from SNC-Lavalin this morning. That's a premium of 33% to the recent share price. With such a premium and the stated support for the offer from the directors, it looks likely to succeed.  This will avoid the directors of Kentz having to deal with the ...
Post Date: June 23, 2014 Read more

AstraZeneca and Pfizer merger definitely off

Pfizer have conceded defeat in their proposed offer for AstraZeneca (AZN). Ian Read, the Chief Executive of Pfizer, said it was a "missed opportunity" for both the UK and for AZN shareholders. He also said we could have had the worlds largest pharmaceutical company domiciled in the UK which would have been good for science and manufacturing in this country. He surely has a point there. In addition he complained about the Takeover Panel rules as contributing to thwarting the deal, but ...
Post Date: May 27, 2014 Read more

Thoughts on AstraZeneca

Shareholders in AstraZeneca are no doubt pleasantly surprised by the uplift in the share price following the offers from Pfizer. The share price has doubled in the last year on improving prospects with an even sharper increase in the last few weeks as soon as a bid was rumoured. That puts the company on a historic p/e of about 20 at the time of writing. AstraZeneca has of course been a dog for some years with falling revenue and earnings, a poor ...
Post Date: May 4, 2014 Read more